Search
for
Sort by
Research 30 of 486
- SAT-358 Hypercalcemia-Induced Altered Mental Status as the Primary Manifestation of Classic Hodgkin Lymphoma
- Hodgkin′s lymphoma presenting as alopecia
- Alopecia areata as a paraneoplastic syndrome of Hodgkin’s lymphoma: A case report
- Side effects of CHOP in the treatment of non-Hodgkin's lymphoma
- Salvage Chemotherapy in Follicular Non-Hodgkin's Lymphoma: Focus on Tolerability
- A Meta-Analysis on the Relationship Between Hair Dye and the Incidence of Non-Hodgkin’s Lymphoma
- Predictive value of the serum albumin change rate for therapeutic response to targeted therapy in patients with AIDS-related non-Hodgkin lymphoma
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- A Primary Adrenal Non-Hodgkin's Lymphoma Presenting as an Incidental Adrenal Mass
- [Chemotherapy for advanced non-Hodgkin's lymphoma with CVP therapy].
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Bexxar, iodine I 131 tositumomab, Effective in Long Term Follow-up of Non-Hodgkin's Lymphoma
- VEPA and ML-Y1 Regimen for Elderly Non-Hodgkin's Lymphoma.
- Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) is the New Standard of Care in the Treatment of Patients with Early Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) Trial HD10
- Peptichemio: A New Oncolytic Drug in Combination with Vincristine and Prednisolone in the Treatment of Non-Hodgkin Lymphomas
- Long-term hair loss associated with brentuximab vedotin–containing chemotherapy and its psychosocial impact: A retrospective observational study conducted at the Royal Marsden Hospital.
- Alopecia Areata and malignancies: uncertainties clarified by a large-scale population-based study
- The Efficacy of Spiritual Healing
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- Lymphoma Specialists Lament the Discontinuation of Underprescribed Bexxar
- Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma
- Rituximab for Bone Lymphoma
- ‘Disappearing Foot Disease’: An Unusual Presentation of Primary Lymphoma of Bone
- Telogen Effluvium as a Sign of Hodgkin Disease
- A supplementary report on the toxic manifestations of CHOP regimen in subjects with intermediate grade NHL
- C001 Lymphoproliferative disorders
- The JAK/STAT signaling pathway: from bench to clinic
- Protein Kinase C as a Therapeutic Target
- VP-16-213 (etoposide): The mandrake root from Issyk-Kul
- Dermatological drugs, topical agents, and cosmetics